On May 5-6, 2023, the 7th Future Medical Top 100 Conference, sponsored by VB100, Artery Network, and Eggshell Research Institute, was held at Zhangjiang Science Hall in Shanghai. At the conference, the "2023 Future Medical Top 100 List" was officially announced.Huaxin Medical was listed on the "2023 Future Medical Top 100 · China's Top 100 Innovative Medical Devices", and its strength was recognized by the industry!The Future Medical Top 100 List, founded in 2015, is the first innovative medical field list targeting non listed enterprises in China launched by VB100, Arterial Network, and Eggshell Research Institute. The aim is to select Chinese innovative medical professionals who truly represent future medical care, discover the core strength of China's future medical industry, and promote the innovation and transformation process of the health and medical industry. Over the past seven years, the selection system for the Top 100 Future Healthcare has been continuously enriched, gradually building a global innovative healthcare selection ecosystem for enterprises, investment institutions, and industrial parks, and expanding into the selection of innovative products and technologies.The 7th Future Medical Top 100 Conference in 2023, with the theme of "No Questions about the West and East", interprets the spirit of medical innovation pioneers. The conference officially kicked off on May 5th and released the 2023 Future Healthcare Top 100 list and the "2023 Future Healthcare Top 100 Enterprise Growth Analysis Report" at the Top 100 Awards Ceremony on the evening of May 6th. This conference will conduct an inventory of the four major tracks of medical devices, biopharmaceuticals, digital healthcare, and medical services, committed to discovering new technologies, formats, and models in the field of big health, and jointly promoting the long-term investment layout of the big health industry.2023 Future Healthcare Top 100Main List · China Innovative Medical Device ListThis selection is aimed at non listed companies in the medical and health field. The selection is based on the VB100 value evaluation model, and through the process of independent application by enterprises, evaluation by the VB100 evaluation meeting, cross evaluation by supporting institutions, and final review by expert committees, the top 100 innovative enterprises with valuation rankings are selected from five major fields (medical devices/biopharmaceuticals/digital healthcare/medical services/commercial and supply chain services). In addition to valuation, the growth and annual performance of candidate companies in four primary indicators, namely human resources, knowledge resources, important partner resources, and market performance, will be supplemented and examined, with a total of 17 secondary indicator data.Huaxin Medical specializes in the fields of disposable endoscopes and specialized robots, integrating research and development, production and sales, and service. Its products cover ICU, respiratory, urology, facial features, animal, and industrial fields. The company has subsidiaries in the United States and Germany, as well as research and development centers in Shanghai, Beijing, Wuhan, Changsha, Shenzhen, and other places. It has invested hundreds of millions of yuan to establish a one-time endoscopic full industry chain production line, with a leading automated production system and a quality certification system that complies with global production. More than 60 certifications have been obtained from China's NMPA, the US FDA, the EU CE, as well as Japan and South Korea. The existing product line has covered over 160 major countries and regions worldwide, achieving a global layout。
Details
The spring breeze is surging and everything is thriving. April is the season for the growth of all things。Huaxin Medical's corporate image IP "Dr. Jack" officially launched！New IP image, new Huaxin vision, "Dr. Jack" will jointly embark on a new brand life journey with Huaxin!By breaking through the sub-dimensions to create the cartoon image of "Dr. Jack" and utilizing the influence of the enterprise to endow the IP with life, we aim to shape a more affable brand super symbol and make "Dr. Jack" an old friend of every doctor and patient! IPStory background A story about love. Dr. Zhou Zhenhua, who once served as the head of product line research and development at the German Wolf brand, unexpectedly found that most hospitals in China did not have endoscopes when accompanying his grandmother to have a lung cancer examination after returning to China. They had to queue up and register in big cities, which was a waste of time and very painful for patients. Reusable endoscopes on the market were expensive and had the risk of cross-infection. Realizing this problem, Dr. Zhou Zhenhua, who has rich experience in the research and practice of disposable medical endoscopes, led a team to establish "Huaxin Medical" in 2018, focusing on the research and development of disposable electronic endoscopes. At the same time, he invested hundreds of millions of yuan to establish a production line for disposable electronic endoscopes of Huaxin Medical and built an ecological platform for the endoscope industry chain. Through technological and production capacity upgrades, the production and use costs of products were reduced, and the market expansion of disposable endoscope products was promoted. Relying on the application of Huaxin's patented riveting snake bone, Huaxin's disposable endoscope not only achieves comparable overall controllability to reusable endoscopes, but also ensures safer and more convenient use, thus easing the doctor-patient relationship from the root. Dr. Zhou Zhenhua also hopes that through the enterprise philosophy of "leaving complexity to ourselves and bringing simplicity to users", ordinary people can also enjoy quality medical products and services, and make Huaxin Medical become the high-tech medical endoscope company that saves the most lives of patients globally.Huaxin Medical has applied for more than 360 patents, including 123 invention patents. The annual number of patent applications is not less than 100, with invention patents accounting for more than 30%. Disposable bronchoscopy has also obtained qualifications such as CE, FDA, NMPA etc, and obtained ISO13485 quality system certification. This is enough to indicate that Huaxin Medical is gradually becoming a medical technology innovator.As mentioned above: I have experienced the difficulties of accompanying my grandmother for medical treatment, and Huaxin Medical has benefited more doctors and patients through continuous innovation. The birth of the cartoon character "Dr. Jack" has been achieved, endowing him with the vitality of Huaxin's corporate personality! In the future, on the path of continuous innovation, we will also apply "Dr. Jack" to more scenarios. If you are interested, why not help customize a growth plan for "Dr. Jack"!
Details
Hunan Province continues to optimize the business environment and promote the simultaneous increase in the quantity and quality of business entities. Huaxin Medical was invited to be interviewed.As the first medical device enterprise to settle in the Hunan Medical Device Industrial Park, Huaxin Medical, under the leadership of Dr. Zhou Zhenhua, focuses on the field of disposable endoscopes and specialized robots. Its products have served hundreds of thousands of patients worldwide, and its business scope covers more than 160 countries and regions worldwide..
Details
Recently, Hunan Huaxin Medical Device Co., Ltd. ("Huaxin Medical") announced that it had completed a Pre-B round of strategic financing of several hundred million yuan, led by IDG Capital and followed by Founder Securities Investment and Xiangtan Caixin Industrial Investment.Founded in 2018, Huaxin Medical specializes in the fourth-generation medical endoscopes, medical specialty robots, and automated precision diagnosis and treatment systems characterized by ultra-miniaturization, high definition, and intelligence. Its research and development products mainly involve medical endoscopes and consumables for respiratory, urology, gastroenterology, anorectal, otolaryngology, gynecology, orthopedics, and other departments.Headquartered in Hunan Xiangtan Economic and Technological Development Zone - Hunan Medical Device Industrial Park, Huaxin Medical is a national high-tech enterprise and a "small giant" enterprise specializing in innovation in Hunan Province. The company has established subsidiaries in Germany, Shanghai, Beijing, Wuhan, Changsha, Shenzhen, and other places. Olympus is the general agent of Huaxin Medical in the United States and an important strategic partner. In addition, the company has also established strategic partnerships with many world-renowned industrial giants. The company's innovative products are sold in dozens of developed countries and regions worldwide, including the United States, Germany, Japan, France, the United Kingdom, Australia, and its business scope covers the globe.Dr. Zhou Zhenhua, Chairman of Huaxin Medical, said, "The birth of disposable endoscope products is a new blue ocean opportunity explored at the edge of the red ocean market. Huaxin Medical shortens the long commercialization cycle through simplified product innovation and technological breakthroughs, creating value that benefits doctors and patients. Huaxin Medical, with a heart full of inclusiveness, enters the market humbly, allowing the development of disposable endoscope products to return to their original purpose as a productive tool to enhance doctors' and hospitals' treatment levels, thereby expanding the boundaries of medical care and achieving the co-creation and prosperity of the entire industry."After the completion of this round of financing, the raised funds will be used to further expand the product research and development pipeline, increase investment in clinical trials, expand automated production lines, strengthen the international market sales layout, and continuously enhance Huaxin Medical's competitiveness in the field of disposable endoscopes. We are grateful to new and old shareholders for their recognition and support of Huaxin Medical. After IDG Capital, Founder Securities Investment, and Xiangtan Caixin Industrial Investment became shareholders of Huaxin, the company's shareholder structure has become increasingly diversified. Each shareholder will also deeply empower Huaxin Medical in business expansion, capital docking, and other aspects, helping Huaxin Medical grow into a leading enterprise in the disposable endoscope industry.About IDG CapitalIDG Capital is a leading global private equity investment institution that pioneered venture capital investment in China in 1993. IDG Capital's investment scope in the medical field covers all stages from startup, growth, maturity, to mergers and acquisitions, with investment scales ranging from millions to hundreds of millions of US dollars. Over the years, IDG Capital has always paid close attention to the development of innovative medical devices. In the cardiovascular field, IDG has invested in Huihe Medical, Yuanxin Technology, and Weimu Medical. In the field of medical robots, IDG has invested in Changgugu and Shuzhidao. In the field of new technologies, IDG has invested in cardiovascular AI solution provider Keya Medical and quantum magnetic field medical application-focused Weici Technology.About Founder Securities InvestmentFounder Securities Investment Co., Ltd. (hereinafter referred to as "Founder Securities Investment") is an alternative investment subsidiary wholly owned by Founder Securities Co., Ltd. It engages in equity investment business with its own funds, mainly focusing on national key encouraged industries such as healthcare, high-end manufacturing, and new-generation information technology.About Xiangtan Caixin Industrial InvestmentHunan Xiangtan Caixin Industrial Investment Equity Investment Partnership (Limited Partnership) (hereinafter referred to as "Xiangtan Caixin Industrial Investment") is an industrial guidance fund jointly established by Hunan Caixin Financial Holding Group and Xiangtan Industrial Investment Development Group. The fund manager, Hunan Caixin Industrial Fund Management Co., Ltd. (hereinafter referred to as "Caixin Industrial Fund"), is a wholly-owned subsidiary of Hunan Caixin Financial Holding Group Co., Ltd. (hereinafter referred to as "Caixin Financial Holding"), a provincial financial holding platform in Hunan Province. Founded in January 2001, Caixin Industrial Fund is one of the first venture capital institutions in Hunan Province. Its business scope includes entrusted management of private equity funds and equity investment funds, entrusted asset management, investment management, venture capital investment, equity investment, etc. It is an important investment platform for Hunan Province to innovate the reform of fiscal investment and financing systems
Details
一、Name and Overview of the Construction ProjectProject Name: Annual Production Expansion Project of 400,000 Medical EndoscopesConstruction Unit: Hunan Huaxin Medical Device Co., Ltd.Project Overview:The project will lease additional space in the Innovation and Entrepreneurship Service Center, specifically the south side of the first floor of Building 11 and the second floor of Building 12, to be used as new production workshops, offices, and warehouses. In addition, new production processes such as composite insertion tubes and NUM board components will be added to the existing processes. The company will produce its own finished products to replace the previously outsourced insertion tubes and NUM boards. A new temporary storage area for hazardous waste will be established, and the overall layout of the factory will be adjusted. After the expansion, the production volume of medical endoscopes will increase from 30,000 units to 400,000 units.二、Name and Contact Information of the Construction UnitConstruction Unit: Hunan Huaxin Medical Device Co., Ltd.Contact Person: Mr. TangContact Number: 0731-55558558三、Name and Contact Information of the Environmental Impact Assessment Agency Responsible for the EvaluationAssessment Unit: Hunan State Grid Environmental Science Research Institute Co., Ltd.Address: No. 6 Jianshe Middle Road, Yuetang District, Xiangtan CityContact Person: Mr. LiuContact Number: 0731-55881598四、Main Matters for Soliciting Public OpinionsThe purpose of public participation is to collect the views, requirements, and aspirations of the people within the scope of the project's impact. If the public has any opinions or suggestions regarding the project construction, please contact the project unit or the environmental impact assessment unit within 10 working days from the date of the announcement. The full version of the "Environmental Impact Report for the Annual Production Expansion Project of 400,000 Medical Endoscopes" is attached.五、Main Ways for the Public to Voice Their OpinionsThe public can contact the project unit or the environmental impact assessment unit through phone calls, letters, or other means.
Details
Follow the Official Accounts
Follow the Channels
Copyright © Hunan Vathin Medical Instrument Co., Ltd. Xiang ICP Record No. 19006866
